StonvexLoading…
StonvexStonvexStonvexCore line items from DTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.24B | $981.00M | $922.00M | $920.00M |
Operating Income | $614.00M | $489.00M | $471.00M | $478.00M |
Net Income | $441.00M | $354.00M | $384.00M | $370.00M |
EPS (Diluted) | $4.30 | $3.60 | $3.94 | $3.81 |
Total Assets | $10.08B | $9.94B | $8.98B | $8.83B |
Total Liabilities | $5.20B | $5.17B | $4.70B | $4.68B |
Cash & Equivalents | $54.00M | $68.00M | $56.00M | $61.00M |
Free Cash Flow OCF − CapEx | $441.00M | $413.00M | $26.00M | $387.00M |
Shares Outstanding | 101.67M | 101.32M | 96.97M | 96.75M |